Devyser's products are sold in over 60 countries and are used to guide targeted cancer therapies, enable genetic testing, and aid in post-transplant follow-up. Their product development focuses on simplifying testing processes to improve throughput, reduce hands-on time, and produce accurate results. Their guiding principle is to make technology simple, reproducible, and less prone to user-generated errors, which is why routine diagnostic laboratories worldwide use their products.